Meininger V - Search Results

1

Does primary lateral sclerosis exist? A study of 20 patients and a review of the literature.

Le Forestier N, Maisonobe T, Piquard A, Rivaud S, Crevier-Buchman L, Salachas F, Pradat PF, Lacomblez L, Meininger V. Le Forestier N, et al. Among authors: meininger v. Brain. 2001 Oct;124(Pt 10):1989-99. doi: 10.1093/brain/124.10.1989. Brain. 2001. PMID: 11571217 Review.

2

[Primary lateral sclerosis: the era of international diagnosis criteria].

Le Forestier N, Meininger V. Le Forestier N, et al. Among authors: meininger v. Rev Neurol (Paris). 2009 May;165(5):415-29. doi: 10.1016/j.neurol.2008.07.022. Epub 2008 Oct 7. Rev Neurol (Paris). 2009. PMID: 18842276 Review. French.

3

Natural history of amyotrophic lateral sclerosis. A discussion.

Meininger V, Bensimon G, Lacomblez L, Salachas F. Meininger V, et al. Adv Neurol. 1995;68:199-207. Adv Neurol. 1995. PMID: 8787230 Review. No abstract available.

4

[What's new in primary lateral sclerosis?].

Le Forestier N, Maisonobe T, Spelle L, Lesort A, Salachas F, Chassande B, Bouche P, Samson Y, Meininger V. Le Forestier N, et al. Among authors: meininger v. Rev Neurol (Paris). 2000 Apr;156(4):364-71. Rev Neurol (Paris). 2000. PMID: 10795013 French.

5

What has changed with riluzole?

Meininger V, Lacomblez L, Salachas F. Meininger V, et al. J Neurol. 2000 Dec;247:19-22. J Neurol. 2000. PMID: 11200701 Review.

6

Primary lateral sclerosis: further clarification.

Le Forestier N, Maisonobe T, Spelle L, Lesort A, Salachas F, Lacomblez L, Samson Y, Bouche P, Meininger V. Le Forestier N, et al. Among authors: meininger v. J Neurol Sci. 2001 Apr 1;185(2):95-100. doi: 10.1016/s0022-510x(01)00469-5. J Neurol Sci. 2001. PMID: 11311289

7

APOE: a potential marker of disease progression in ALS.

Lacomblez L, Doppler V, Beucler I, Costes G, Salachas F, Raisonnier A, Le Forestier N, Pradat PF, Bruckert E, Meininger V. Lacomblez L, et al. Among authors: meininger v. Neurology. 2002 Apr 9;58(7):1112-4. doi: 10.1212/wnl.58.7.1112. Neurology. 2002. PMID: 11940705

8

[Nocturnal oxymetry in patients with amyotrophic lateral sclerosis: role in predicting survival].

Velasco R, Salachas F, Munerati E, Le Forestier N, Pradat PF, Lacomblez L, Orvoen Frija E, Meininger V. Velasco R, et al. Among authors: meininger v. Rev Neurol (Paris). 2002 May;158(5 Pt 1):575-8. Rev Neurol (Paris). 2002. PMID: 12072825 French.

9

Dyslipidemia is a protective factor in amyotrophic lateral sclerosis.

Dupuis L, Corcia P, Fergani A, Gonzalez De Aguilar JL, Bonnefont-Rousselot D, Bittar R, Seilhean D, Hauw JJ, Lacomblez L, Loeffler JP, Meininger V. Dupuis L, et al. Among authors: meininger v. Neurology. 2008 Mar 25;70(13):1004-9. doi: 10.1212/01.wnl.0000285080.70324.27. Epub 2008 Jan 16. Neurology. 2008. PMID: 18199832

10

[Parkinson disease and amyotrophic lateral sclerosis. Tauopathies, TDP-43 and SOD mutations].

Le Forestier N, Lacomblez L, Meininger V. Le Forestier N, et al. Among authors: meininger v. Rev Neurol (Paris). 2009 Jan;165(1):15-30. doi: 10.1016/j.neurol.2008.02.043. Epub 2008 Jun 24. Rev Neurol (Paris). 2009. PMID: 18808763 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

310 results

Search Page